Assessing rationality of resource allocation in a psychiatric facility
https://doi.org/10.17749/2070-4909/farmakoekonomika.2026.375
Abstract
Objective: To demonstrate the financialandclinicalvalue of ABC/VENanalysisforevaluating the rationalityofresource allocation underbudgetary constraints.
Material and methods. Data from the inventory and expenditure records of a psychiatric facility for the period 2022–2024 were analyzed. Pharmaceutical expenditures were calculated (ABC-analysis), and rational medicine use was assessed (VEN-analysis). The categories and structure of expenditures were evaluated using ABC/VEN matrix analysis. Spearman’s correlation coefficient and an optimization coefficient were calculated to determine the relationships between variables and evaluate the rationality of resource allocation in terms of the alignment of expenditures with clinical significance.
Results. During the analyzed period, the share of Category I expenditures increased both in terms of the number of subcategories (from 57.9% to 86.66%) and costs (from 84.7% to 96.98%). Conversely, the share of Category II decreased both in terms of the number of items (from 38.6% to 10.34%) and costs (from 14.6% to 3.02%). Category III expenditures (low-priority drugs) were gradually eliminated from the procurement structure, dropping from 3.5% to complete absence in 2024. An increase was observed in the optimization coefficient for Subcategory AV (up to 0.47 in 2023–2024), alongside a growth in the share of expenditures for Group V medicines from 48% to 97%. Subcategories AN and AE were completely eliminated, and the correlation between the shares of medicine items and expenditures became stronger.
Conclusion. In 2022–2024, the procurement structure realigned toward Category I, which is consistent with the principles of evidence-based medicine and the strategic objectives of expenditure optimization while maintaining a high level of therapeutic efficacy.
About the Authors
N. K. Alimov
Kyrgyz-Russian Slavic University named after the First President of the Russian Federation B.N. Yeltsin
Kyrgyzstan
Kyrgyzstan
Nursultan K. Alimov
44 Kievskaya Str., Bishkek 720000, Kyrgyz Republic
A. T. Sharaeva
Kyrgyz-Russian Slavic University named after the First President of the Russian Federation B.N. Yeltsin
Kyrgyzstan
Kyrgyzstan
Ainura T. Sharaeva, PhD, Assoc. Prof.
44 Kievskaya Str., Bishkek 720000, Kyrgyz Republic
A. A. Zurdinova
Kyrgyz-Russian Slavic University named after the First President of the Russian Federation B.N. Yeltsin
Kyrgyzstan
Kyrgyzstan
Aida A. Zurdinova, Dr. Sci. Med., Assoc. Prof.
WoS ResearcherID: A-8343-2019, Scopus Author ID: 57698479700
44 Kievskaya Str., Bishkek 720000, Kyrgyz Republic
References
1. Mfizi E., Niragire F., Bizimana T., Mukanyangezi M.F. Analysis of pharmaceutical inventory management based on ABC-VEN analysis in Rwanda: a case study of Nyamagabe district. J Pharm Policy Pract. 2023; 16 (1): 30. https://doi.org/10.1186/s40545-023-00540-5.
2. Prachhai D.B., Dawadi S., Kharel S., et al. Strategic inventory control in hospital pharmacies: an ABC-VED approach in a hospital of developing country, Nepal. Int J Silkroad Inst Res Train. 2025; 3 (1): 1–8. https://doi.org/10.3126/ijsirt.v3i1.81804.
3. Faleiros D.R., Álvares J., Almeida A.M., et al. Budget impact analysis of medicines: updated systematic review and implications. Expert Rev Pharmacoecon Outcomes Res. 2016; 16 (2): 257–66. https://doi.org/10.1586/14737167.2016.1159958.
4. Damayanti D., Suprapti B., Andarsari M.R., et al. ABC-VEN analysis of drug use in outpatients at a neurology department in Indonesia. Pharm Educ. 2024; 24 (3): 63–8. https://doi.org/10.46542/pe.2024.243.6368.
5. Tacer E., Ozban H. Improvement of drug stock management using ABC‑VED analysis in a university hospital. Clin Exp Health Sci. 2024; 14 (3): 618–24. https://doi.org/10.33808/clinexphealthsci.1204223.
6. Altawalbeh S.M. Sallam N.M., Al-Khatib M., et ak. Clinical pharmacist-led medication reconciliation supplemented with medication review in admitted patients with chronic kidney disease: a cost-benefit analysis. BMJ Open. 2025; 15 (2): e087232. https://doi.org/10.1136/bmjopen-2024-087232.
7. Van De Sijpe G., Gijsen M., Van der Linden L., et al. A prediction model to identify clinically relevant medication discrepancies at the emergency department (MED-REC Predictor): development and validation study. J Med Internet Res. 2024; 26: e55185. https://doi.org/10.2196/55185.
8. Zennaro M., Trotter A., Mengato D., et al. Improving medication safety through medication reconciliation in pediatric neurology: clinical pharmacist recommendations and physician uptake in a 13-week study. Children. 2025; 12 (5): 625. https://doi.org/10.3390/children12050625.
9. Fu R., Ng V., Liu M., et al. Considering patient perspectives in economic evaluations of health interventions. Front Public Health. 2023; 11: 1212583. https://doi.org/10.3389/fpubh.2023.1212583.
10. Sittimart M., Rattanavipapong W., Mirelman A.J., et al. An overview of the perspectives used in health economic evaluations. Cost Eff Resour Alloc. 2024; 22 (1): 41. https://doi.org/10.1186/s12962-024-00552-1.
11. Al-Hanawi M.K., Keetile M. Determinants of out-of-pocket expenditure on medicines among adults in Saudi Arabia: a cross-sectional study. Front Med. 2024; 11: 1478412. https://doi.org/10.3389/fmed.2024.1478412.
12. Kaiser A.H., Mao S., Sundewall J., et al. Assessing the determinants of out-of-pocket health expenditures among Cambodian households in informal employment using survey data. Int J Equity Health. 2025; 24 (1): 33. https://doi.org/10.1186/s12939-025-02394-6.
13. Mori A., Mnandi P., Kagashe G., et al. ABC-VEN analysis of medicine expenditure at Mwananyamala Regional Hospital in Tanzania. Modern Economy. 2021; 12 (1-): 1449–62. https://doi.org/10.4236/me.2021.1210074.
14. Devnani M., Gupta A.K., Nigah R. ABC and VED analysis of the pharmacy store of a tertiary care teaching, research and referral healthcare institute of India. J Young Pharm. 2010; 2 (2): 201–5. https://doi.org/10.4103/0975-1483.63170.
15. Agafonova J.A. Pharmacoeconomic study of oral anticancer therapy: results of combined ABC/VEN and frequency analysis. FARMAKOEKONOMIKA. Sovremennaya farmakoekonomika i farmakoepidemiologiya / FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology. 2025; 18 (2): 164–74 (in Russ.). https://doi.org/10.17749/2070-4909/farmakoekonomika.2025.318.
16. Burbello A.T., Fedorenko A.S., Latariya E.L., et al. Clinical and economic analysis of drug costs in a general hospital in 2014–2018. FARMAKOEKONOMIKA. Sovremennaya farmakoekonomika i farmakoepidemiologiya / FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology. 2019; 12 (4): 291–9 (in Russ.). https://doi.org/10.17749/2070-4909.2019.12.4.291-299.
17. Blotskaya N.G., Mikhailova E.I., Palkovsky O.L. ABC/VEN analysis of drug consumption at the level of an intensive care and resuscitation unit of a maternity hospital. Health and Ecology Issues. 2022; 19 (3): 46–51 (in Russ.). https://doi.org/10.51523/2708-6011.2022-19-3-06.
Review
For citations:
Alimov N.K., Sharaeva A.T., Zurdinova A.A. Assessing rationality of resource allocation in a psychiatric facility. FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology. (In Russ.) https://doi.org/10.17749/2070-4909/farmakoekonomika.2026.375
Views:
129
JATS XML
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Email this article 